paper-writer
VerifiedMedical/scientific paper writing workflow skill. Manages the full pipeline from literature search to submission-ready manuscript. Creates and manages a project directory with IMRAD-format section files, literature matrix, reference management, and quality checklists. Supports both English and Japanese papers. Triggers: 'write paper', 'paper-write', 'start manuscript', '論文を書く', '論文執筆', '論文プロジェクト', 'manuscript', 'research paper', '原稿作成'.
templates/sr-rob.md
View on GitHub# Risk of Bias Assessment Templates
> This file contains assessment templates for the four most commonly used RoB tools.
> Select the appropriate tool based on study design.
> All assessments must be performed independently by two reviewers.
---
## Tool Selection Guide
| Study Design | Recommended Tool | Reference |
|-------------|-----------------|-----------|
| Randomized controlled trials | Cochrane RoB 2 | Sterne et al., BMJ 2019;366:l4898 |
| Cohort studies | Newcastle-Ottawa Scale (NOS) | Wells et al. (Ottawa Hospital Research Institute) |
| Case-control studies | Newcastle-Ottawa Scale (NOS) | Wells et al. (Ottawa Hospital Research Institute) |
| Cross-sectional studies | JBI Critical Appraisal Checklist | Moola et al., JBI Manual 2020 |
| Diagnostic accuracy studies | QUADAS-2 | Whiting et al., Ann Intern Med 2011;155:529-536 |
---
## Two-Reviewer Independent Assessment Protocol
### Procedure
1. **Training:** Both reviewers complete tool-specific training before assessment.
2. **Calibration:** Independently assess 2-3 pilot studies and compare results.
3. **Independent assessment:** Each reviewer completes the form without discussion.
4. **Comparison:** After both reviewers finish, compare all judgments.
5. **Resolution:** Discuss disagreements; involve a third reviewer if consensus is not reached.
6. **Documentation:** Record the final judgment, supporting evidence, and resolution method.
### Agreement Reporting
| Metric | Formula | Interpretation |
|--------|---------|---------------|
| Percent agreement | (Agreements / Total domains) x 100 | >80% is acceptable |
| Cohen kappa | (Po - Pe) / (1 - Pe) | <0.40 poor; 0.41-0.60 moderate; 0.61-0.80 substantial; >0.80 almost perfect |
---
## 1. Cochrane Risk of Bias 2 (RoB 2) -- For Randomized Controlled Trials
### Study: {{AUTHOR}} ({{YEAR}})
**Assessed for outcome:** {{OUTCOME}}
**Reviewer 1:** {{REVIEWER_1}} | **Reviewer 2:** {{REVIEWER_2}} | **Date:** {{DATE}}
---
### Domain 1: Risk of Bias Arising from the Randomization Process
| # | Signaling Question | Response | Support |
|---|-------------------|----------|---------|
| 1.1 | Was the allocation sequence random? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 1.2 | Was the allocation sequence concealed until participants were enrolled and assigned to interventions? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 1.3 | Did baseline differences between intervention groups suggest a problem with the randomization process? | Y / PY / PN / N / NI | {{SUPPORT}} |
**Domain 1 judgment:** Low / Some concerns / High
**Rationale:** {{RATIONALE}}
---
### Domain 2: Risk of Bias Due to Deviations from the Intended Interventions
**(Effect of assignment to intervention -- intention-to-treat)**
| # | Signaling Question | Response | Support |
|---|-------------------|----------|---------|
| 2.1 | Were participants aware of their assigned intervention during the trial? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 2.2 | Were carers and people delivering the interventions aware of participants' assigned intervention during the trial? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 2.3 | If Y/PY to 2.1 or 2.2: Were there deviations from the intended intervention that arose because of the trial context? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
| 2.4 | If Y/PY to 2.3: Were these deviations likely to have affected the outcome? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
| 2.5 | If Y/PY to 2.4: Were these deviations from intended intervention balanced between groups? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
| 2.6 | Was an appropriate analysis used to estimate the effect of assignment to intervention? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 2.7 | If N/PN to 2.6: Was there potential for a substantial impact (on the result) of the failure to analyze participants in the group to which they were randomized? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
**Domain 2 judgment:** Low / Some concerns / High
**Rationale:** {{RATIONALE}}
---
### Domain 3: Risk of Bias Due to Missing Outcome Data
| # | Signaling Question | Response | Support |
|---|-------------------|----------|---------|
| 3.1 | Were data for this outcome available for all, or nearly all, participants randomized? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 3.2 | If N/PN to 3.1: Is there evidence that the result was not biased by missing outcome data? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
| 3.3 | If N/PN to 3.2: Could missingness in the outcome depend on its true value? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
| 3.4 | If Y/PY to 3.3: Is it likely that missingness in the outcome depended on its true value? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
**Domain 3 judgment:** Low / Some concerns / High
**Rationale:** {{RATIONALE}}
---
### Domain 4: Risk of Bias in Measurement of the Outcome
| # | Signaling Question | Response | Support |
|---|-------------------|----------|---------|
| 4.1 | Was the method of measuring the outcome inappropriate? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 4.2 | Could measurement or ascertainment of the outcome have differed between intervention groups? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 4.3 | If N/PN to 4.1 and 4.2: Were outcome assessors aware of the intervention received by study participants? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 4.4 | If Y/PY to 4.3: Could assessment of the outcome have been influenced by knowledge of intervention received? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
| 4.5 | If Y/PY to 4.4: Is it likely that assessment of the outcome was influenced by knowledge of intervention received? | Y / PY / PN / N / NI / NA | {{SUPPORT}} |
**Domain 4 judgment:** Low / Some concerns / High
**Rationale:** {{RATIONALE}}
---
### Domain 5: Risk of Bias in Selection of the Reported Result
| # | Signaling Question | Response | Support |
|---|-------------------|----------|---------|
| 5.1 | Were the data that produced this result analyzed in accordance with a pre-specified analysis plan that was finalized before unblinded outcome data were available for analysis? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 5.2 | Is the numerical result being assessed likely to have been selected, on the basis of the results, from multiple eligible outcome measurements within the outcome domain? | Y / PY / PN / N / NI | {{SUPPORT}} |
| 5.3 | Is the numerical result being assessed likely to have been selected, on the basis of the results, from multiple eligible analyses of the data? | Y / PY / PN / N / NI | {{SUPPORT}} |
**Domain 5 judgment:** Low / Some concerns / High
**Rationale:** {{RATIONALE}}
---
### Overall RoB 2 Judgment
| Domain | Judgment |
|--------|----------|
| 1. Randomization process | Low / Some concerns / High |
| 2. Deviations from intended interventions | Low / Some concerns / High |
| 3. Missing outcome data | Low / Some concerns / High |
| 4. Measurement of the outcome | Low / Some concerns / High |
| 5. Selection of the reported result | Low / Some concerns / High |
| **Overall** | **Low / Some concerns / High** |
**Overall algorithm:**
- **Low risk:** All domains are low risk
- **Some concerns:** Some concerns in at least one domain, but no high risk in any domain
- **High risk:** High risk in at least one domain; OR some concerns in multiple domains in a way that substantially lowers confidence
**Response key:** Y = Yes, PY = Probably yes, PN = Probably no, N = No, NI = No information, NA = Not applicable
---
## 2. Newcastle-Ottawa Scale (NOS) -- For Cohort and Case-Control Studies
### 2A. NOS for Cohort Studies
**Study:** {{AUTHOR}} ({{YEAR}})
**Reviewer:** {{REVIEWER}} | **Date:** {{DATE}}
Maximum score: 9 stars. Thresholds: Good quality >= 7; Fair quality 5-6; Poor quality < 5.
#### Selection (max 4 stars)
| # | Item | Options | Stars |
|---|------|---------|-------|
| 1 | **Representativeness of the exposed cohort** | a) Truly representative of the average in the community [*] | |
| | | b) Somewhat representative of the average in the community [*] | |
| | | c) Selected group of users (e.g., nurses, volunteers) | |
| | | d) No description of the derivation of the cohort | |
| 2 | **Selection of the non-exposed cohort** | a) Drawn from the same community as the exposed cohort [*] | |
| | | b) Drawn from a different source | |
| | | c) No description of the derivation of the non-exposed cohort | |
| 3 | **Ascertainment of exposure** | a) Secure record (e.g., surgical records) [*] | |
| | | b) Structured interview [*] | |
| | | c) Written self-report | |
| | | d) No description | |
| 4 | **Demonstration that outcome of interest was not present at start of study** | a) Yes [*] | |
| | | b) No | |
**Selection stars:** {{N}} / 4
#### Comparability (max 2 stars)
| # | Item | Options | Stars |
|---|------|---------|-------|
| 5 | **Comparability of cohorts on the basis of the design or analysis** | a) Study controls for {{MOST_IMPORTANT_FACTOR}} [*] | |
| | | b) Study controls for any additional factor [*] | |
**Comparability stars:** {{N}} / 2
#### Outcome (max 3 stars)
| # | Item | Options | Stars |
|---|------|---------|-------|
| 6 | **Assessment of outcome** | a) Independent blind assessment [*] | |
| | | b) Record linkage [*] | |
| | | c) Self-report | |
| | | d) No description | |
| 7 | **Was follow-up long enough for outcomes to occur** | a) Yes (adequate follow-up period for outcome of interest) [*] | |
| | | b) No | |
| 8 | **Adequacy of follow-up of cohorts** | a) Complete follow-up (all subjects accounted for) [*] | |
| | | b) Subjects lost to follow-up unlikely to introduce bias (<=20% lost; or description provided of those lost) [*] | |
| | | c) Follow-up rate <80% and no description of those lost | |
| | | d) No statement | |
**Outcome stars:** {{N}} / 3
**Total NOS score:** {{TOTAL}} / 9 -- Quality: Good / Fair / Poor
---
### 2B. NOS for Case-Control Studies
**Study:** {{AUTHOR}} ({{YEAR}})
**Reviewer:** {{REVIEWER}} | **Date:** {{DATE}}
Maximum score: 9 stars. Thresholds: Good quality >= 7; Fair quality 5-6; Poor quality < 5.
#### Selection (max 4 stars)
| # | Item | Options | Stars |
|---|------|---------|-------|
| 1 | **Is the case definition adequate?** | a) Yes, with independent validation [*] | |
| | | b) Yes, e.g., record linkage or based on self-reports | |
| | | c) No description | |
| 2 | **Representativeness of the cases** | a) Consecutive or obviously representative series of cases [*] | |
| | | b) Potential for selection biases or not stated | |
| 3 | **Selection of controls** | a) Community controls [*] | |
| | | b) Hospital controls | |
| | | c) No description | |
| 4 | **Definition of controls** | a) No history of disease (endpoint) [*] | |
| | | b) No description of source | |
#### Comparability (max 2 stars)
| # | Item | Options | Stars |
|---|------|---------|-------|
| 5 | **Comparability of cases and controls on the basis of the design or analysis** | a) Study controls for {{MOST_IMPORTANT_FACTOR}} [*] | |
| | | b) Study controls for any additional factor [*] | |
#### Exposure (max 3 stars)
| # | Item | Options | Stars |
|---|------|---------|-------|
| 6 | **Ascertainment of exposure** | a) Secure record (e.g., surgical records) [*] | |
| | | b) Structured interview where blind to case/control status [*] | |
| | | c) Interview not blinded to case/control status | |
| | | d) Written self-report or medical record only | |
| | | e) No description | |
| 7 | **Same method of ascertainment for cases and controls** | a) Yes [*] | |
| | | b) No | |
| 8 | **Non-response rate** | a) Same rate for both groups [*] | |
| | | b) Non-respondents described | |
| | | c) Rate different and no designation | |
**Total NOS score:** {{TOTAL}} / 9 -- Quality: Good / Fair / Poor
---
## 3. JBI Critical Appraisal Checklist for Analytical Cross-Sectional Studies
**Study:** {{AUTHOR}} ({{YEAR}})
**Reviewer:** {{REVIEWER}} | **Date:** {{DATE}}
| # | Question | Yes | No | Unclear | N/A |
|---|----------|-----|----|---------|-----|
| 1 | Were the criteria for inclusion in the sample clearly defined? | | | | |
| 2 | Were the study subjects and the setting described in detail? | | | | |
| 3 | Was the exposure measured in a valid and reliable way? | | | | |
| 4 | Were objective, standard criteria used for measurement of the condition? | | | | |
| 5 | Were confounding factors identified? | | | | |
| 6 | Were strategies to deal with confounding factors stated? | | | | |
| 7 | Were the outcomes measured in a valid and reliable way? | | | | |
| 8 | Was appropriate statistical analysis used? | | | | |
**Overall appraisal:** Include / Exclude / Seek further info
**Scoring guidance:**
- **Low risk:** 6 or more "Yes" responses with no critical items as "No"
- **Moderate risk:** 4-5 "Yes" responses
- **High risk:** 3 or fewer "Yes" responses or critical items (Q3, Q4, Q7) as "No"
**Rationale:** {{RATIONALE}}
---
## 4. QUADAS-2 -- For Diagnostic Accuracy Studies
**Study:** {{AUTHOR}} ({{YEAR}})
**Index test:** {{INDEX_TEST}}
**Reference standard:** {{REFERENCE_STANDARD}}
**Target condition:** {{TARGET_CONDITION}}
**Reviewer:** {{REVIEWER}} | **Date:** {{DATE}}
---
### Domain 1: Patient Selection
**Signaling questions:**
| # | Question | Response | Support |
|---|----------|----------|---------|
| 1 | Was a consecutive or random sample of patients enrolled? | Y / N / Unclear | {{SUPPORT}} |
| 2 | Was a case-control design avoided? | Y / N / Unclear | {{SUPPORT}} |
| 3 | Did the study avoid inappropriate exclusions? | Y / N / Unclear | {{SUPPORT}} |
**Risk of bias:** Low / High / Unclear
**Concerns regarding applicability:** Low / High / Unclear
---
### Domain 2: Index Test
**Signaling questions:**
| # | Question | Response | Support |
|---|----------|----------|---------|
| 1 | Were the index test results interpreted without knowledge of the results of the reference standard? | Y / N / Unclear | {{SUPPORT}} |
| 2 | If a threshold was used, was it pre-specified? | Y / N / Unclear | {{SUPPORT}} |
**Risk of bias:** Low / High / Unclear
**Concerns regarding applicability:** Low / High / Unclear
---
### Domain 3: Reference Standard
**Signaling questions:**
| # | Question | Response | Support |
|---|----------|----------|---------|
| 1 | Is the reference standard likely to correctly classify the target condition? | Y / N / Unclear | {{SUPPORT}} |
| 2 | Were the reference standard results interpreted without knowledge of the results of the index test? | Y / N / Unclear | {{SUPPORT}} |
**Risk of bias:** Low / High / Unclear
**Concerns regarding applicability:** Low / High / Unclear
---
### Domain 4: Flow and Timing
**Signaling questions:**
| # | Question | Response | Support |
|---|----------|----------|---------|
| 1 | Was there an appropriate interval between index test and reference standard? | Y / N / Unclear | {{SUPPORT}} |
| 2 | Did all patients receive the same reference standard? | Y / N / Unclear | {{SUPPORT}} |
| 3 | Were all patients included in the analysis? | Y / N / Unclear | {{SUPPORT}} |
**Risk of bias:** Low / High / Unclear
---
### QUADAS-2 Summary
| Domain | Risk of Bias | Applicability Concerns |
|--------|-------------|----------------------|
| Patient selection | Low / High / Unclear | Low / High / Unclear |
| Index test | Low / High / Unclear | Low / High / Unclear |
| Reference standard | Low / High / Unclear | Low / High / Unclear |
| Flow and timing | Low / High / Unclear | -- |
---
## 5. Traffic Light Visualization Guide
### Creating Traffic Light Plots
Traffic light plots display per-study, per-domain risk of bias judgments using colored indicators.
**Color coding:**
| Color | RoB 2 / QUADAS-2 | NOS | JBI |
|-------|-------------------|-----|-----|
| Green | Low risk | Good quality (>= 7) | Low risk (>= 6 Yes) |
| Yellow | Some concerns / Unclear | Fair quality (5-6) | Moderate risk (4-5 Yes) |
| Red | High risk | Poor quality (< 5) | High risk (<= 3 Yes) |
### Recommended Software
| Tool | Type | URL |
|------|------|-----|
| robvis | R package | https://github.com/mcguinlu/robvis |
| Risk-of-bias VISualization (robvis) | Web app | https://www.riskofbias.info/welcome/robvis-visualization-tool |
| RevMan | Desktop | Cochrane RevMan |
### robvis R Code Example
```r
# Install
install.packages("robvis")
library(robvis)
# Prepare data (RoB 2 example)
# CSV with columns: Study, D1, D2, D3, D4, D5, Overall
# Values: "Low" / "Some concerns" / "High"
data <- read.csv("rob_data.csv")
# Traffic light plot
rob_traffic_light(data, tool = "ROB2")
# Summary bar plot
rob_summary(data, tool = "ROB2")
# Available tools: "ROB2", "ROBINS-I", "QUADAS-2", "ROB1"
```
### Figure Formatting for Publication
- Use high resolution (>= 300 DPI)
- Include a legend explaining the color coding
- Label all domains clearly
- Order studies alphabetically or by year
- Export as PDF or TIFF for journal submission
- Caption example: "Figure X. Risk of bias assessment of included randomized controlled trials using the Cochrane Risk of Bias 2 tool. Green (+) = low risk; Yellow (?) = some concerns; Red (-) = high risk."
---
## 6. Summary Tables Across All Included Studies
Use these aggregate tables to present RoB results across all included studies in the manuscript.
### For RoB 2 (RCTs)
| Study | D1: Randomization | D2: Deviations | D3: Missing Data | D4: Measurement | D5: Selection | Overall |
|-------|-------------------|----------------|-----------------|----------------|---------------|---------|
| {{STUDY_1}} | L / SC / H | L / SC / H | L / SC / H | L / SC / H | L / SC / H | L / SC / H |
| {{STUDY_2}} | | | | | | |
| {{STUDY_3}} | | | | | | |
L = Low risk, SC = Some concerns, H = High risk
### For NOS (Cohort/Case-Control)
| Study | Selection (/4) | Comparability (/2) | Outcome (/3) | Total (/9) | Quality |
|-------|---------------|-------------------|--------------|-----------|---------|
| {{STUDY_1}} | {{N}} | {{N}} | {{N}} | {{TOTAL}} | Good / Fair / Poor |
| {{STUDY_2}} | | | | | |
| {{STUDY_3}} | | | | | |
### For JBI (Cross-Sectional)
| Study | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Yes Count | Risk |
|-------|----|----|----|----|----|----|----|----|-----------|------|
| {{STUDY_1}} | Y/N/U | Y/N/U | Y/N/U | Y/N/U | Y/N/U | Y/N/U | Y/N/U | Y/N/U | {{N}}/8 | L/M/H |
| {{STUDY_2}} | | | | | | | | | | |
### For QUADAS-2 (Diagnostic Accuracy)
| Study | Patient Selection (RoB / App) | Index Test (RoB / App) | Reference Standard (RoB / App) | Flow and Timing (RoB) |
|-------|------------------------------|----------------------|-------------------------------|----------------------|
| {{STUDY_1}} | L/H/U / L/H/U | L/H/U / L/H/U | L/H/U / L/H/U | L/H/U |
| {{STUDY_2}} | | | | |
L = Low, H = High, U = Unclear, App = Applicability concerns
Related skills
| Skill | Stars | Updated | Works with | Status | Install |
|---|---|---|---|---|---|
| writing-skillsobra/superpowersUse when creating new skills, editing existing skills, or verifying skills work before deployment | Stars: 322k | Updated | Claude CodeCodex | Verified | Install |
| xlsxanthropics/skillsUse this skill any time a spreadsheet file is the primary input or output. This means any task where the user wants to: open, read, edit, or fix an existing .xlsx, .xlsm, .xltx, .csv, or .tsv file (e.g., adding columns, computing formulas, formatting, charting, cleaning messy data); create a new spreadsheet from scratch or from other data sources; or convert between tabular file formats. Trigger especially when the user references a spreadsheet file by name or path — even casually (like "the xlsx in my downloads") — and wants something done to it or produced from it. Also trigger for cleaning or restructuring messy tabular data files (malformed rows, misplaced headers, junk data) into proper spreadsheets. The deliverable must be a spreadsheet file. Do NOT trigger when the primary deliverable is a Word document, HTML report, standalone Python script, database pipeline, or Google Sheets API integration, even if tabular data is involved. | Stars: 198k | Updated | Claude CodeCodex | Verified | Install |
| shipping-and-launchaddyosmani/agent-skillsPrepares production launches. Use when preparing to deploy to production, or when asking what needs to be in place before shipping. Use when you need a pre-launch checklist, when setting up monitoring, when planning a staged rollout, or when you need a rollback strategy. | Stars: 119k | Updated | Claude CodeCodex | Verified | Install |
| childhoodthedotmack/claude-memBabysit a shipped release after merge, publication, or deployment. Verify published packages, production behavior, installed plugins, and late CI or user reports until the observation window is clean; use babysit for PR readiness before release. | Stars: 118k | Updated | Claude CodeCodex | Verified | Install |